Last reviewed · How we verify

Iodixanol (Visipaque) — Competitive Intelligence Brief

Iodixanol (Visipaque) (Iodixanol (Visipaque)) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Non-ionic iso-osmolar contrast medium. Area: Diagnostic Imaging / Radiology.

marketed Non-ionic iso-osmolar contrast medium Diagnostic Imaging / Radiology Small molecule Live · refreshed every 30 min

Target snapshot

Iodixanol (Visipaque) (Iodixanol (Visipaque)) — Chinese PLA General Hospital. Iodixanol is a non-ionic, iso-osmolar contrast medium that provides radiographic visualization of blood vessels and organs during diagnostic imaging procedures.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Iodixanol (Visipaque) TARGET Iodixanol (Visipaque) Chinese PLA General Hospital marketed Non-ionic iso-osmolar contrast medium
Visipaque - Hydrocortancyl Visipaque - Hydrocortancyl Assistance Publique - Hôpitaux de Paris marketed Non-ionic iso-osmolar contrast medium
VISIPAQUE 270 VISIPAQUE 270 Bracco Diagnostics, Inc marketed Non-ionic iso-osmolar contrast medium
contrast agent (iodixanol) contrast agent (iodixanol) Seoul National University Bundang Hospital marketed Non-ionic iso-osmolar contrast medium

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Non-ionic iso-osmolar contrast medium class)

  1. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
  2. Bracco Diagnostics, Inc · 1 drug in this class
  3. Chinese PLA General Hospital · 1 drug in this class
  4. Seoul National University Bundang Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Iodixanol (Visipaque) — Competitive Intelligence Brief. https://druglandscape.com/ci/iodixanol-visipaque. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: